Filed before 2025Filed 13 January 2021
GeneCentric Therapeutics, Inc. raised $1.2M
GeneCentric Therapeutics, Inc., a biotech company based in Durham, NC, raised $1.2M in a new debt round, according to a filing dated 13 January 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 13 January 2021
- Round
- Debt round
- Amount sold
- $1.2M
- Offering size
- $1.2M
- Investors so far
- 4
- Based in
- Durham, NC
- Website
- genecentric.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 9% of the 2,220 tracked raises with an amount filed in 2021, and than 8% of the 177 in biotech.
GeneCentric Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Jun 2025 | New filing | $2M | Another raise |
| 20 Sep 2022 | New filing | $2.5M | Another raise |
| 7 Oct 2021 | New filing | $4.5M | Another raise |
| 13 Jan 2021 | New filing | $1.2M | This raise |
| 5 Jan 2017 | New filing | $6.11M | Another raise |
| 11 Jul 2014 | Amended filing | $5M | Another raise |
More with Hatteras on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.